[1]
S. Samir, “Rate of Epstein-Barr Virus in Gastric Adenocarcinoma in Egyptian Patients in View of the WHO Classification and Correlation with p16 Immunoreactivity”, Open Access Maced J Med Sci, vol. 10, no. A, pp. 1218–1225, Jun. 2022.